"The eyes are a window to how well the brain is working and functioning." Our CEO, Dr. Rosina S., recently spoke about the eye-tracking technology behind EyeBOX with David Brancaccio for NPR’s Marketplace. Check out the full interview here: https://lnkd.in/gzGXyKJj
OCULOGICA
Medical Device
The EyeBOX takes the guesswork out of concussion assessment for more precise diagnosis and treatment.
About us
The EyeBOX is as powerful as it is easy to use. In under 4 minutes, Oculogica’s proprietary technology collects and analyzes over 100,000 data points across 67-domains of eye movement to generate an objective assessment of concussion that is unique to each patient. 2020 Fast Company Most Creative Companies. Detailed, real-time information on TBI and concussion facilitates rapid and precise diagnosis and improved patient outcomes. The EyeBOX requires no baseline data nor individual calibration, and therefore results cannot be influenced by patient will. Baseline-free Proprietary EyeBOX technology generates quick and accurate analysis without the need for pre-incident patient data. Objective 67-point analysis enables greater diagnostic precision and improved patient outcomes. Unlike current standards of care, the EyeBOX goes beyond symptoms to measure brain function. Easy to Use Simple, calibration-free testing requires no literacy, language fluency or the ability to follow special directions. Accurate evaluation can be achieved in pre-verbal and verbally impaired patients.
- Website
-
http://www.oculogica.com
External link for OCULOGICA
- Industry
- Medical Device
- Company size
- 11-50 employees
- Headquarters
- New York
- Type
- Privately Held
- Founded
- 2013
- Specialties
- Neuro-diagnostics, Brain Injury, TBI, Concussion, and Eye Tracking
Locations
-
Primary
Get directions
33 Irving Pl
New York, 10003, US
Employees at OCULOGICA
-
Dan Sanderson
Principal Software Engineer at Oculogica Inc
-
Greg Kunst
Leading Biotech CEO with Award-Winning Cell Therapy Expertise
-
Prattipati Laxminarain
Seasoned Medtech leader with global experience. Now helping medical device start-ups deliver their promise
-
Mathilde Coste
CFO | SaaS | MedTech | Rapid growth | VC & PE backed | Mid-size | Board Director
Updates
-
We're thankful for the fabulous community of concussion care providers and our team here at Oculogica. Check out these EyeBOX logos made by one of the littlest members of our community - we might just have to start using them on our EyeBOX and OcuPro devices! Wishing you all a wonderful Thanksgiving with friends and family ❤️
-
-
November is National Entrepreneurship Month! Oculogica is proud to be a women-founded and led company. Our founder, Dr. Uzma Samadani and our CEO Dr. Rosina S. are both entrepreneurs who are improving the medical technology space and creating a safer world for everyone. Their journey as entrepreneurs has led to the creation of breakthrough technology that can track eyes to accurately assess brain functionality. We're honored to continue growing Oculogica, helping more clinicians and patients safely treat brain injuries and see better outcomes.
-
-
Our CEO Dr. Rosina S. was interviewed by David Brancaccio for NPR’s Marketplace Morning Report. She spoke about angel investors Golden Seeds and bringing a concussion diagnostic to market. Thank you to David Brancaccio and the Marketplace team for the conversation! Check out the full segment here: https://lnkd.in/gzGXyKJj
-
Don't miss David Brancaccio's of NPR's #morningmarketplace discussion with our CEO Dr. Rosina S. tomorrow morning! They'll chat about #startups, women in #angelinvesting, in particular the pioneers at Golden Seeds, and the future of #concussion diagnosis. At 6:50 am ET and every hour after that all morning.
-
Listen in on Marketplace by APM with David Brancaccio Tuesday 11/19 as he interviews our CEO Dr. Rosina S.! Every hour from 6:50 AM ET to 10:50 am ET.
Exciting news! David Brancaccio of Marketplace Morning Report recently spoke with us about angel investing, the growth of women angels, and how this increasing participation is impacting women entrepreneurs. Conversations will air on Monday 11/18 and Tuesday 11/19 on Marketplace by APM. Tune in to hear what Deb Kemper, Managing Partner at Golden Seeds Venture Fund, and Golden Seeds co-CEO Loretta McCarthy had to say about the progress women are making in the angel market. You'll also hear from Rosina S., President and CEO of OCULOGICA, a Golden Seeds company, about her experience raising capital and working with our angel investors. You can listen live at wnyc.org and on your local NPR station. Catch it every hour starting at 6:50am ET until 10:50am ET. #GoldenSeeds #AngelInvesting #Entrepreneurs #WomenLed
-
-
Congratulations and a big thank you to Golden Seeds on 20 important years supporting women founders! We loved being a part of the panel last night in NYC, and your portfolio.
Last night, we hosted our 20th anniversary celebration in New York City at the offices of ArentFox Schiff. We welcomed current and past Golden Seeds members, entrepreneurs, ecosystem partners and supporters to join us in reflecting on the past two decades of investing in women-led companies and to celebrate the progress we have made. In total, Golden Seeds has invested $185 million in over 250 companies. The program was kicked off by Golden Seeds co-CEOs Loretta McCarthy and Jo Ann Corkran, who discussed the history of Golden Seeds as well as the growth of women angels, entrepreneurs and women-led companies since 2004. Maggie McGrath, editor of ForbesWomen and anchor of ForbesTV, hosted a panel discussion that featured Alison J. Malloy, Co-Founder and Former CEO of Design2Launch Software, Rosina S., President and CEO of OCULOGICA, and Minna Song, Co-Founder and CEO of EliseAI. They shared insights on their incredible journeys as entrepreneurs and the impact Golden Seeds had on their success. Following the panel, Veronica Dagher, The Wall Street Journal Personal Finance Reporter, interviewed Marcia Dawood, Former Chair of the Angel Capital Association and current Golden Seeds member, who discussed her book "Doing Good While Doing Well" and her experiences helping entrepreneurs bridge the gap from early-stage ideas to building thriving, profitable companies. It was a gratifying evening full of comradery, celebration and reflection that brought together Golden Seeds supporters from all walks of life to commemorate our accomplishments to this point and to look forward to the future of angel investing and our continued work in striving toward gender parity in this exciting, ever-evolving industry. Thank you to Golden Seeds member Sarah A. W. Fitts and ArentFox Schiff for graciously hosting us, and to everyone whose dedication made this event such a success. #GoldenSeeds #AngelInvesting #Entrepreneurs #WomenLed
-
-
Have we mentioned how proud we are of our founder Dr. Uzma Samadani ? This week she’s talking about epidural spinal cord stimulation at the XX Congresso Nazionale SIMS in Milan.
Delighted to be in Milan to talk about epidural spinal cord stimulation for spinal cord injury at the XX Congresso Nazionale SIMS. Was an added bonus to visit with Drs Michelle Spinelli and Laura Lippa (who is now in charge of neurosurgical trauma for all of Italy!!) today at Ospedale Niguarda, as they work on programming for their first epidural stim spinal cord injured patient. #sci #injury #trauma #wins #italy
-
-
OCULOGICA reposted this
Getting back to daily activities is one of the best things kids can do as part of recovery from a concussion--including school and light exercise that doesn't risk another head injury. Experts like Christina Master, MD, FAAP, FACSM, FAMSSM, Toni Grishman, David Howell and Julie Wilson at Children's Hospital Colorado talk about new Colorado guidelines and best practices in my article for KFF Health News and US News & World Report https://lnkd.in/gTFdGVUk
-
In a recent episode of “New Heights”, Jason Kelce emphasized the need for more longterm concussion research and ways to mitigate symptoms. There’s a lot of good research being done right now that looks into the effects of concussion. Of course, even more research and information is necessary and we hope to learn more about the symptoms and effects of concussion as athletes continue to speak out about it. Improving how concussion is tested for and diagnosed is important as well. Testing earlier and having objective results is a critical step towards mitigating the symptoms. We appreciate Jason Kelce for advocating for better concussion protocols! Let’s make sports safer for everyone! 🧠
-